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Abstract 
Emergence agitation (EA) is common among pediatric patients undergoing general 
anesthesia.  Sevoflurane is a volatile anesthetic that is associated with an increased 
incidence of EA of as high as 80% in children undergoing surgery. Emergence agitation 
can cause increased stress in the patient, nurses and caregivers.  Agitation experienced by 
the patient can also increase the risk of self harm, delay medical treatments, damage 
equipment and ultimately increase the length of stay in the hospital.  Current studies lack 
a consistent method of quantifying and recognizing EA in a standardized manner.  The 
development of the Pediatric Anesthesia Emergence Delirium (PAED) scale provided a 
reliable and accurate tool to assess EA in pediatric patients. Propofol has been used in 
sub-hypnotic doses to reduce both the incidence and severity of EA. The purpose of this 
systematic review was to examine the current literature to determine if there is an effect 
on PAED scores of patients that undergo general anesthesia with sevoflurane after 
receiving an intravenous dose of propofol prior to emergence. This systematic review 
was created using guidelines put forth by both PRISMA and CONSORT.  A literature 
review was performed and data were collected from each study. A cross study analysis 
was performed using data collection tables created by the author of this systematic 
review.  Propofol was found to decrease both the incidence and severity of EA in 
pediatric patients undergoing ophthalmic, inguinal hernia repair, adenostonsillectomies 
and non-painful procedures such as MRI scans.  By incorporating the use of propofol in 
the anesthetic plan for pediatric patients, anesthesia providers will be able to decrease the 
incidence the EA and its’ associated adverse outcomes. 
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Propofol And Emergence Agitation In The Pediatric Population: A Systematic Review 
Background/Statement of the Problem 
Approximately four million children undergo general anesthesia each year in the 
United States (Miller et al., 2015).  One of the most common inhalation anesthetic agents 
used in pediatric general anesthesia is sevoflurane. Sevoflurane is a volatile anesthetic 
that allows for a rapid induction as well as timely emergence related to its low blood gas 
coefficient. It is these same reasons that may also make sevoflurane one of the leading 
causes of emergence agitation in the pediatric population.  Sevoflurane has been 
associated with an incidence rate of emergence agitation as high as 80% in children 
(Kim, Yoon, Lim & Yoon, 2011). 
Emergence agitation (EA) can occur after general anesthesia and includes 
behaviors such as crying, disorientation, excitement and delirium (Miller et al., 2015).  
These children can suffer from paranoid delusions and display restlessness that can 
quickly escalate to combative behavior (Vlajkovic & Sindjelic, 2007).  Although the 
condition is self-limiting, the increased risk of patient injury and stress experienced by 
both the patient and their care giver(s) have made the limitation of EA a focus of research 
(Kim, Moon, Kim & Lee, 2012).  These patients are also at a greater risk of disrupting 
medical treatments and equipment, requiring extra nursing care and ultimately requiring a 
longer length of stay (Vlajkovic & Sindjelic, 2007). 
There are many tools available for both the reporting and rating of EA.  Due to 
the questionable validity and reliability of the tools that were presently available, the 
pediatric anesthesia emergence delirium scale (PAED) was developed (Sikich & Lerman, 
2004). The scale consists of five scale items by which the patient is evaluated. These 
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items include; eye contact, purposeful actions, awareness of surroundings, restlessness 
and consolability (Sikich & Lerman) (Figure 1).  
 
Figure 1.  PAED scoring tool 
Each item is scored numerically between 1 and 4 and the sums of the individual 
scores comprise the total PAED score.  The degree of emergence agitation is directly 
correlated with increasing scores.  “A score of >4 (from crying and difficult to console to 
wild thrashing) for a five or more minute duration despite active calming efforts is 
regarded as indicative of emergence delirium” (Reduque & Verghese, 2012, p.1).  The 
internal consistency of the scoring tool was 0.89 along with a reliability rating of 0.84 
(95% confidence interval, 0.76-0.90) (Sikich & Lerman, 2004). The authors developed 
three hypotheses to further validate the PAED scale. The first hypothesis was supported, 
with the scores having a negative correlation with the age of the patient (r =-0.31, 
P<0.04).  The second hypothesis also showed a negative correlation with the score but in 
relation to the awakening time (r=-0.5, P <0.001).  The PAED scores were found to be 
higher after the administration of sevoflurane compared to that of halothane (P <0.008) 
with a sensitivity of 0.64 (Sikich & Lerman). 
Many medications have been used prophylactically to decrease the incidence of 
EA including fentanyl, ketamine, midazolam and most recently dexmedetomidine 
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(Precedex).  Propofol has also been used as an adjunct medication for the prevention of 
EA. Propofol is a hypnotic sedative that achieves its anesthetic effect by inhibiting 
GABA receptors in the central nervous system (Nagelhout & Plaus, 2014).  It is often 
used as an induction agent for pediatric anesthesia when given intravenously at a dose of 
2-3 mg/kg (Nagelhout & Plaus).  Propofol used at sub-hypnotic doses (1 mg/kg) at the 
end of general anesthesia has been found to decrease the incidence of EA when 
sevoflurane was used as the primary inhalation anesthetic (Messieha, 2013). 
The purpose of this paper was to present a systematic review conducted to 
determine if the administration of propofol decreases the incidence of EA as evidenced 
by decreased PAED scores after the use of sevoflurane during general anesthesia in the 
pediatric population. 
Next, the review of the literature will be presented. 
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Literature Review 
Emergence agitation is a global phenomenon within the pediatric patient 
population. Key, Rich, DeCristofaro and Colllins (2010) conducted a literature review 
with the goal of evaluating the incidence of EA in children that were administered 
anesthesia in three categories: sevoflurane alone, propofol as an adjunct to sevoflurane 
and propofol used as a total intravenous anesthesia technique. The literature review 
examined a total of 10 randomized control trials.  Three trials used sevoflurane as the sole 
anesthetic, five used propofol for total intravenous anesthesia and the final two studies 
used propofol as an adjunct anesthetic at the end of the surgery.  A total of 1172 children 
aged 1- 6 years old were included in the studies. A higher incidence of EA within the 
sevoflurane only studies was reported as compared to those patients that received 
propofol either at the end of the surgery or as part of a total intravenous anesthetic.  
Children that underwent procedures were found to have EA rates ranging from 50-60% 
when sevoflurane was given as the sole anesthetic agent.  Emergence agitation incidence 
rates dropped to 4.8% - 19% and 3.7% - 11% with the propofol adjunct and TIVA groups 
respectively. 
Although the literature review conducted by Key et al. (2010) could demonstrate 
a direct correlation between the administration of propofol and the decreased incidence of 
EA, there were many limitations that affected the overall strength of the findings.  One of 
the key discrepancies occurring throughout the review is the lack of a consistent 
measurement tool of emergence agitation.  Some studies used a four-point scale; others 
used the PAED tool while others were not specified.  This lack of consistency can affect 
the validity of the review.  The information lacking in this particular literature review 
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inspired the problem statement for this systematic review by limiting the EA tool to 
include only the PAED scale. 
Studies Using the PAED Scale to Measure EA in Pediatric Subjects 
Inguinal hernia repair. There were several randomized control trials that utilized 
the PAED as their primary tool for measuring pediatric emergence delirium.  One such 
trial compared the administration of both propofol and fentanyl in the effective 
prevention of EA related to sevoflurane anesthesia (Kim et al., 2012).  This randomized 
double blinded control trial involved 205 children aged 18 -72 months of age.  All of the 
children were scheduled to undergo an inguinal hernia repair and were considered in 
good health with ASA ratings of no greater than II. Each of the participants were 
randomly assigned to either the propofol group (group P: n = 69), the fentanyl group 
(group F: n = 66), or the placebo group, which received saline (group S: n = 70). At the 
completion of the surgery, each participant received the dosing of assigned medication: 
propofol dosed at 1mg/kg; fentanyl dosed at 1µg/kg; and 2ml of saline.  Upon arrival to 
the post-anesthesia care unit (PACU) the PAED scale was used every five minutes for the 
first 30 minutes after arrival on the unit. The mean PAED score was 4.3 for group P and 
4.9 in group F (P = 0.682), which were lower than the mean of 9.0 in group S (P < 
0.001). This trial demonstrated a significant decrease in the PAED score for the pediatric 
patients that received a sub-hypnotic dose of both the propofol and fentanyl.  Limitations 
of the study include the lack of variety of procedures performed which decreases the 
generalizability of the results of the study.  All of the patients underwent an inguinal 
hernia repair.  “Emergence agitation is different depending on the type of surgery and is 
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known to be higher in otorhinolaryngological or ophthalmological procedures” (Kim et 
al., p.279). 
Opthalmic procedures. Strabismus correction is a commonly performed 
ophthalmologic surgical procedure in the pediatric population. Aouad et al. (2007) 
performed a randomized double-blind study that aimed to determine if a single dose of 
propofol given at the end of sevoflurane anesthesia would decrease the incidence of EA 
after strabismus surgery.  Eighty children aged 2-6 years that were scheduled for elective 
strabismus surgery were selected for the study.  Children were randomly assigned to the 
propofol group (n = 41) and the saline placebo group (n = 39).  The propofol group 
received 1mg/kg at the end of surgery where as the placebo group received an equal 
volume of saline. 
The PAED scores were obtained and the mean scores of the propofol group (8.6 + 
3.9; P = 0.004) were much lower than the saline group (11.5 + 4.5; P = 0.004).  The 
scores were generally higher in relation to those obtained during the trial involving the 
inguinal hernia procedures, but still demonstrated a reduction in the appearance and 
severity of EA. Limitations of this study involved the use of the PAED tool.  One of the 
evaluation items included making eye contact with the caregiver that would have been 
hard to determine with unilateral ocular dressings. 
Although not as common as strabismus surgery, cataract surgery is also 
performed in the pediatric population. A study conducted by Chen, Li, Hu & Wang 
(2010) set forth to determine if the use of sub-hypnotic doses of propofol, ketamine or 
midazolam would decrease the incidence of EA after cataract surgery performed under a 
sevoflurane anesthetic using the PAED tool.  A total of 120 children aged 1-7 were 
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selected to participate.  All of the patients were scheduled for an elective cataract removal 
procedure and were randomly assigned to one of three postoperative groups (n = 40): 
midazolam (MF) group, propofol (PF) group and the ketamine (KF) group.  At the end of 
the procedure, as the sevoflurane was being discontinued the patients received a dose of 
medications based on which group they were assigned to. The MF group received 
0.05mg/kg of midazolam, the PF group received 1 mg/ kg of propofol and the KF group 
received 0.25 mg/kg of ketamine.  The patients were then evaluated for EA in the PACU 
at 5,10, 15 and 30-minute intervals using the PAED assessment tool. The peak scores 
were recorded and a value of > 10 was considered indicative of EA. 
The number of patients with a PAED score >10 in the KF group were 18 (45%) 
and the number of patients that had scores > 15 were 10 (25%).  The MF and PF group 
demonstrated a much lower percentages of PAED scores > 10 with only 15% (P = 
0.0034) and 20% (P = 0.017) respectively.  The PAED scores that were >15 within the 
MF group were only 2.5% (P = 0.0035) and the PF group had only 7.5% (P = 0.0339) of 
the patients with an elevated score.  
Although this study illustrates a clear reduction in the PAED score in those 
patients that received a sub-hypnotic dose of propofol, there were also limitations.  The 
lack of a placebo group weakens the study design.  The author stated that the decision to 
not include a placebo group was based on ethical reasons and considerations (Chen et 
al.). 
Adenotonsillectomy procedures. Adenotonsillectomy procedures are commonly 
performed in the pediatric population.  A randomized control trial conducted by Lee et al. 
(2010) set forth to determine if a single dose of propofol given at the end of anesthesia 
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would decrease the incidence and severity of EA when sevoflurane was administered.  
Ninety children between the ages of 3-8 years were selected to participate in the study.  
All of the participants were scheduled for an elective adenotonsillectomy and were 
randomly assigned into two groups.  One group received propofol at1 mg/kg (n = 45) and 
the other group received saline at 0.1ml/kg (n = 45) at the end of the surgery.  Emergence 
delirium and agitation was then measured using the PAED scale at 5 (T5), 15 (T15) and 
30 (T30) minute intervals after emergence.  
The incidence of EA in the propofol group was lower when compared to the 
saline group at the T5, T15 and T30 marks.  The mean scores of the PAED scale at T5, 
T15 and T30 were 12.6 + 4.6, 8.2 + 3.8, and 5.0 + 3.1 respectively in the propofol group 
while 13.8 + 4.7, 8.0 + 3.9 and 4.5 + 3.1 in the saline group.  Although there was not a 
significant reduction in the incidence or severity of EA at the T5 or T15 time marks, the 
effectiveness was more clearly demonstrated at T30.  The authors did not recommend the 
administration of propofol after adenotonsillectomy surgery and stated that further studies 
were needed in order to better differentiate between post-operative pain and agitation 
(Lee et al.). 
Another study conducted by Ali & Abdellatif (2013) also focused on the 
prevention of sevoflurane related EA in children undergoing adenotonsillectomy and the 
effectiveness of propofol and dexmedetomidine as preventative medications.  A total of 
120 children aged 2-6 years old were selected that had been scheduled for an elective 
adenotonsillectomy.  The patients were randomly assigned to one of three groups: those 
that received 10ml of 0.9% normal saline (Group C, n = 40); those that received 1mg/kg 
propofol (Group P, n = 40); and those that received 0.3µg/kg of dexmedetomidine (Group 
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D, n = 40).  All of the study groups received their doses of medication five minutes prior 
to the conclusion of the procedure.  The PAED scores were assessed at 5 (T5), 10(T10) 
and 15(T15) minute intervals.  The incidence of EA within Groups P and D were lower 
compared to that of Group C.  At T5, Group C (saline) had a mean PAED score of 8.4 + 
4.5, Group P (propofol) had a mean score of 6.6 + 3.2, and Group D (dexmedetomidine) 
had a mean score of 5.2 + 2.9.  Compared to group D, the incidence and severity of EA in 
group P were significantly higher at T0, T5, and T15 but not T 30.  This trial 
demonstrated that although propofol reduces the overall PAED scores when compared to 
a placebo, it also has a higher incidence of EA when compared to other adjuvants such as 
dexmedetomidine.  The effectiveness of propofol didn’t exceed that of dexmedetomidine 
until 30 minutes after the emergence from anesthesia. 
Non-painful procedures.  The previous trials all include surgical procedures that 
are both stimulating and associated with a significant amount of post surgical pain.  One 
randomized control trial that was conducted by Abu-Shahwan (2008) focused on the 
effects of propofol on EA after the administration of sevoflurane anesthesia for non-
painful procedures. 84 children between the ages of 2-7 years old were selected for the 
study.  The patients were all scheduled to undergo a magnetic resonance imaging (MRI) 
study that required general anesthesia. No surgical interventions were necessary and there 
were no expectations of peri- or post-procedure pain.  The patients were randomly 
assigned to either group P which received 1mg/kg propofol prior to emergence or group S 
which received only a placebo dose of saline.  The PAED scoring system was used 
during the first 30 minutes after emergence for each of the groups. The peak PAED 
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scores for the propofol group was 7 compared to the peak score of 13 of the saline group.  
Both the groups’ peak PAED scores were associated with a P value <0.05. 
A more recent randomized control trial conducted by Costi et al. (2015) involved 
pediatric patients scheduled to complete MRI procedures under general anesthesia.  A 
total of 230 children aged from 1 to 12 years old where randomly assigned to either 
receive a propofol bolus of 3mg/kg over 3 minutes or no intervention at the end of 
general anesthesia comprised of inhaled sevoflurane.  The group receiving the propofol 
bolus had a decreased incidence of EA as well lower PAED scores.  The percentage of 
patients presenting with EA in the propofol group, compared to that of the placebo group 
were 7% and 29 % respectively with a confidence interval of 0.12-0.52 and P < 0.001. 
Although this study did not use a sub-hypnotic dose of propofol, the administration of 
3mg/kg over a period of three minutes had a significant effect on the incidence of EA 
based on PAED scores.  This trial was included as a discussion point for the need for 
further research regarding the range of dosages and the concurrent effects on EA. 
In summary, the administration of propofol prior to emergence from sevoflurane 
anesthesia decreased the PAED scores in all of the randomized control trials reviewed. 
Next, the theoretical framework utilized for this systematic review will be discussed. 
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 Theoretical Framework  
The emphasis on evidence based practice and its influence on the development of 
new clinical guidelines have made systematic reviews and meta-analyses the cornerstone 
of present day healthcare.  Systematic reviews can provide the basis for changes in the 
delivery of care and therefore the strength and validity of their content must be 
scrutinized.  The preferred reporting items for systematic reviews and meta-analyses 
(PRISMA) statement was used to guide the creation of this systematic review (Moher, 
Liberati, Tetzlaff & Altman, 2009).  The PRISMA guidelines were created in order to not 
only improve the quality of review reporting, but also to assist in the assessment of a 
systematic review’s strengths and weaknesses. Both the PRISMA checklist and flow 
diagram were used to insure the creation of a strong and relevant systematic review. 
The PRISMA checklist (Appendix A) contains 27 evidence-based items that were 
used in developing and reporting this systematic review (Moher et al., 2009). These items 
included factors such as title, abstract, introduction, methods, data collection processes, 
synthesis of results, bias reporting and limitations.  While creating this systematic review 
the author referred to the checklist and insured that all items were addressed within the 
report.   
 The PRISMA tool also includes a flow diagram, illustrated on the following page 
(Figure 2), that assisted in the process and organization of the literature review. The flow  
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Figure 2. PRISMA Flowchart (Moher et al., 2009) 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For	more	information,	visit	www.prisma-statement.org. 
 
PRISMA	2009	Flow	Diagram 
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chart organized the search results based on both inclusion and exclusion criteria 
determined by the author of the review.  The end result provided a final number of 
studies that were included in the systematic review.  The PRISMA guidelines provided a 
framework in which the author could create a relevant and strong systematic review.  
 In addition to the PRISMA checklist and flowchart, the author also utilized the 
consolidated standards of reporting trials framework (CONSORT, 2010) (Appendix B) 
checklist to further evaluate and insure the quality of the randomized control trials that 
were reported.  The CONSORT checklist was designed to specifically examine 
randomized control trials and evaluate their strengths, weaknesses and limitations. It is 
also utilized to identify sources of bias.  This checklist was used for the critical appraisal 
for each of the articles used for the creation of this systematic review. There are 25 items 
on the checklist including items such as trial design, eligibility of participants, sample 
size determination, randomization methods, blinding, limitations, statistical methods and 
generalizability.   
 All of the randomized clinical control trials included within this systematic review 
were also evaluated across the studies.  The PAED scores, emergence times, discharge 
times and adverse effects were compared among the control and interventional groups 
within the seven trials.  This information was recorded within a data collection table 
created by the author of this review to compare the effects of propofol on these outcomes. 
 Next, the methods section will be presented and discussed. 
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Method 
Purpose 
The purpose of this paper was to present a systematic review conducted to 
determine if the administration of propofol decreases the incidence of EA as evidenced 
by decreased PAED scores after the use of sevoflurane during general anesthesia in the 
pediatric population. 
Inclusion/Exclusion Criteria 
Inclusion criteria consisted of randomized clinical trials, meta-analyses or 
systematic reviews conducting in the last 10 years that included the following: pediatric 
surgical population (ages six months to 18 years); elective surgical procedures; use of 
sevoflurane for general anesthesia, use of PAED as assessment tool for measuring 
emergence agitation, ASA I -III; and propofol given at or near the end of the procedure 
(within 15 minutes). 
Exclusion criteria included: use of alternate tools for assessment of EA; studies 
conducted in foreign languages; literature over 10 years old; ASA IV patients or 
emergent cases; adult patients; use of isoflurane or desflurane; conscious or moderate 
sedation; propofol given at the beginning of the procedure or over 30 minutes prior to the 
conclusion of surgery; and studies that consisted of less than 20 subjects. 
Search Strategy  
The literature search was performed using both the Pubmed and Medline 
databases.  An initial generalized search was conducted by using the keyword “Propofol” 
within each database.  A total of 2730 articles were located within Pubmed and an 
additional 17,308 articles were available through Medline.  The search was narrowed by 
the addition of a second keyword “Emergence Agitation”.  The results from both Pubmed 
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and Medline were drastically reduced to 56 and 54 items respectively.  A final filter was 
placed on the search limiting the publication of the literature between the years of 2005 
and 2015, as well as restricting the results to those articles that focused on human 
subjects only, were written in English and published in peer reviewed journals.  The final 
search yielded 38 articles from Pubmed and 30 articles from Medline. 
Data Collection  
The randomized control trials (RCT) were reviewed and relevant data collected 
for further analysis.  In an effort to analyze the influence of not only propofol on PAED 
scores, but also other variables presented within the randomized control trials, two tables 
were created for data collection and comparisons across studies.  
The first table was designed to record basic information about the randomized 
control trials including author, year of study, number of patients included in the study, 
ages of participants, gender, ASA score, procedure performed, procedure duration and 
allocation of participants into control and interventional groups (Table 1). 
Table 1 
Data Collection Sheet #1 
Author,Year # Pt in 
Trial 
Ages 
(yr) 
M/F ASA Procedure Duration 
(min) 
Propofol 
Group 
Interventional 
Group 
         
         
         
         
         
         
         
 
  A second table was designed to collect data on other variables that may have 
influenced PAED scores within the trials including interventional dose and timing of the 
 16 
administration, timing of obtainment of PAED scores, parental presence, timing of 
emergence and discharge from PACU as well as any adverse events (Appendix C). 
Critical Appraisal 
The CONSORT method (Appendix B) was used to critically appraise the 
randomized control trials included within this systematic review. The 25-item checklist 
was used to identify strengths, weaknesses, biases and limitations of each of the trials. 
The items include identification of trial design, eligibility and selection of participants, 
settings, sample size, interventions, randomization methods, limitations and funding. 
A flow diagram designed by CONSORT, illustrated in Figure 3 on the next page, 
was utilized to further assess and determine the overall strength and weaknesses of the 
randomized control trials.  The diagram focuses on the sample size, randomization, 
allocation of participants and those participants that may have been lost during follow up 
and analysis.  A flow diagram was completed for each randomized control trial used for 
this systematic review  
A table was created in order to facilitate the collection and organization of data 
concerning the strengths, methods of sampling, randomization, funding and limitations of 
each randomized clinical trial (Appendix D).  These were constructed through the 
information obtained by utilizing both the PRISMA and CONSORT checklists and flow 
diagrams.  This method provided a more succinct and valuable assessment tool. 
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Figure 3. CONSORT Flow Diagram (CONSORT, 20
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Data Synthesis & Cross Study Analysis 
 The data collection tools created to extract information from the randomized 
control trials were utilized in both synthesizing the data and analyzing the data across the 
studies. A cross study analysis was performed that evaluated the effects of propofol on 
overall PAED scores, emergence times, discharge times and the development of any 
adverse events that occurred during the study.  The data were entered in the table 
depicted below (Table 2) and the results will be described later in this paper. 
Table 2 
Cross Study Analysis 
Author, Year 
Type of 
Procedure 
Propofol Group 
–affect on  
PAED scores 
Propofol Group 
Affect on 
Emergence Times 
Propofol Group 
Affect on 
Discharge Time 
Adverse 
Events 
     
     
     
     
     
     
 
 Next, the results section will be discussed. 
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Results 
 The PRISMA flowchart (Appendix E), along with the inclusion and exclusion 
criteria previously mentioned, were used to further eliminate and select articles that were 
appropriate for the systematic review.  There were several duplicate articles found within 
both the databases, and after their elimination, a total of 32 articles remained for review. 
The abstracts of these articles were reviewed for evidence of exclusion criteria that would 
deem them not appropriate for the systematic review.  This process eliminated a total of 
10 articles.  The remaining 22 articles were reviewed in their entirety for relevance and 
selected for the systematic review based on both the exclusion and inclusion criteria.  
This final elimination process omitted 14 articles from the search results, leaving a total 
of 8 articles for inclusion within the systematic review. 
 Of the eight articles that remained, seven were randomized control trials with only 
one literature review that was relevant to the purpose of this systematic review.  The 
seven randomized control trials met the inclusion criteria and were used in the creation of 
this systematic review.  The following is a summary of results obtained from the data 
collection sheets.  The results are organized per similar procedures performed as 
previously categorized in the literature review section. 
Non-Painful Procedures 
The randomized control trial conducted by Abu-Shahwan (2008) (Appendix F- 
1a, 2a) included 83 pediatric patients ranging from 2-7 years old with a 1:1 male to 
female ratio. Patients underwent outpatient MRI procedures and all had ASA scores 
below 2.  The mean duration of the procedures was 73 minutes.  The patients were 
induced using a mask inhalation method utilizing a combination of sevoflurane and 
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nitrous oxide. A laryngeal mask airway with pressure support ventilation was used during 
the procedure. Anesthesia was maintained using 2% sevoflurane and a mixture of 60% 
nitrous oxide and 40% oxygen mixture. At the completion of the procedure the propofol 
group (n = 42) received 1mg/kg of propofol intravenously and the saline group (n = 41) 
received 0.9% normal saline in an unspecified amount. The LMA was removed once 
regular respirations were obtained and before the patient fully emerged from the 
anesthetic. Emergence occurred in the post recovery area with parents present at the 
discretion of a recovery nurse. There was no additional data provided indicating the 
percentage of patients with parents present at emergence.  The degree of agitation was 
measured using the PAED scoring system upon awakening and then every 5 minutes 
during the first 30 minutes after admission to the recovery area. The peak PAED score 
was recorded for evaluation. The propofol group had a peak PAED score of 7 (P < 0.05), 
where as the saline group had a peak score of 13 (P < 0.05).  There were no adverse 
physiologic events noted for either group of patients. Emergence (eye opening) times for 
the propofol and saline groups were 9 + 3.4 minutes and 7 + 2.7 minutes respectively. 
The time to discharge for the propofol group was 31.21 + 6.1 minutes and the saline 
group required 33.4 + 5.8 minutes before being discharged from the recovery area. 
The study conducted by Abu-Shahwan (Appendix F-3a) was able to collect 
significant data, despite a small sample size, with PAED scores that were obtained with a 
P value of <0.05.  The PAED scores were further compared between the groups using the 
Mann-Whitney U-test and Fisher’s exact test.  Although the results are generalizable to a 
vast majority of pediatric patients, the lack of specified timing of interventions and data 
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concerning the initial assessment and recruitment of patients weakened the results of the 
study.   
Using the CONSORT framework, a flow diagram was constructed that assessed 
the sample size, eligibility, exclusion criteria, randomization and attrition of the 
participants within the study (Appendix G-1).  There was a substantial amount of data not 
reported within the study.  Data including initial sample size, number of patients 
excluded prior to randomization and the associated rationale were not available. There 
was just one exclusion reported of a patient within the control group who had received 
propofol during the study. 
Costi et al. (2015) (Appendix F-1b, 2b) also conducted a randomized control trial 
focusing on pediatric patients undergoing MRI procedures.  The study included 218 
patients ranging from the ages of 1 -12 years of age.  All the participants were an ASA 2 
or less.  109 participants were randomly assigned to a control group and the remaining 
One hundred and nine participants were administered 3 mg/kg of propofol at the 
completion of the MRI.  Oral midazolam (0.5 mg/kg) was administered pre-operatively 
and the patient was either induced with sevoflurane and oxygen or with propofol 
intravenously.  An LMA was placed and anesthesia maintained with an unspecified 
concentration of sevoflurane and nitrous oxide.  The PAED scores were obtained upon 
arrival to the PACU and at 5-minute intervals for the first 30 minutes.  Peak PAED scores 
and ranges for each group were reported.  The control group had a peak PAED score of 
10 (P < 0.001) with a range of 6-13.   The group that received propofol had a peak PAED 
score of 6 (P < 0.001) with a range of 2-10.  The average emergence times of the propofol 
and control group were 17 + 10 minutes and 9 + 10 minutes respectively (P < 0.001).  
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The average discharge time from the PACU was 95 + 38 minutes for the propofol group 
and 99 + 48 minutes for the control group (P = 0.573).   Whether there was parental 
presence during recovery was not specified.  Laryngospasm was noted in three patients in 
the control group and only one patient from the propofol group.  No other adverse events 
were reported.  
There were both strengths and weaknesses noted within the study conducted by 
Costi (Appendix F-3b).  The study reported data that included significantly reduced 
PAED scores within the propofol group with a P value of <0.001.  These data were 
further analyzed using the Shapiro-Wilks test.  Limitations of this trial include 
administration of a higher dose of propofol (3mg/kg) than that of the other trials within 
this systematic review, as well as some participants being administered propofol upon 
induction despite being part of the control group. 
The study conducted by Costi (Appendix G-2) reported their participant selection 
and allocation using the CONSORT flow diagram.  Twelve participants were excluded 
from the initial selection due to refusal to participate.  A large sample size consisting of 
230 participants completed the study and were included in the final analysis. 
Adenotonsillectomy procedures 
 The trial conducted by Ali and Abedellatif (2013) (Appendix F-1c, 2c) compared 
the effects of dexmedetomidine and propofol on the severity of EA within a pediatric 
population undergoing adenotonsillectomy procedures. The study included 120 patients 
with ages ranging from 2-6 years old.  There were 69 males and 51 females that 
completed the trial, all of which had an ASA score of 2 or less.  The procedures had a 
mean duration of 58 minutes.  The patients were administered oral midazolam (0.5mg/kg) 
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pre-operatively.  General anesthesia was induced with mask inhalation with sevoflurane 
and nitrous oxide.  Endotracheal intubation was performed with the aid of rocuronium 
(0.6mg/kg) and general anesthesia was maintained with sevoflurane (2-3%) combined 
with a 60% concentration of nitrous oxide and 40% oxygen mixture.  Antiemetic 
medications including dexamethasone and paracetamol were administered 
perioperatively.  Reversal with atropine and neostigmine was utilized prior to extubation.  
Five minutes before the conclusion of the surgery 40 patients were administered 1 mg/kg 
propofol intravenously. A control group consisting of 40 patients was given  
10ml of normal saline and the remaining 40 patients received 0.3mg/kg of 
dexmedetomidine.  Each intervention was administered over a period of five minutes.  
PAED scores were obtained at four different time intervals; upon arrival to the recovery 
areas and then at five, 15 and 30 minute intervals.   
The saline group had the overall highest PAED scores with an average of 13.7 + 
at the time of the arrival to the recovery room, and 7 patients had PAED scores greater 
than 15.  Those patients that received propofol prior to emergence had an average PAED 
score of 11.6 + 3.8 and only two patients with PAED scores greater than 15.  The 
precedex group had the lowest PAED scores with an average of 9.8 + 3.5 upon arrival to 
the PACU with only two patients with PAED scores greater than 15.  All participants had 
parental presence once arriving to PACU.  The emergence times were the greatest among 
the propofol group at 12.3 minutes compared to the saline and precedex groups at 10.7 
minutes and 10.9 minutes respectively.  Discharge from the PACU times were the 
greatest among the precedex groups at 40.1 minutes, followed by the propofol group at 
38.5 minutes and the saline group which averaged a time of 10.7 minutes.  Vomiting 
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occurring in five patients receiving propofol, four that received precedex and three that 
were part of the saline interventional group.  No other adverse events were noted. 
 The trial conducted by Ali and Abedellatif (Appendix F-3c) reported a significant 
decrease in the PAED scores of both those participants that received propofol and in 
those that received precedex. Both results were reported with a P value of <0.05. The 
larger sample size and the frequency of the procedure performed in the pediatric 
population strengthened the data collected for this systematic review.  Other than the lack 
of information concerning the initial participant selection and exclusion data, this study 
had very few limitations. 
 Using the CONSORT framework a flow diagram was constructed in an attempt to 
assess the sample size, eligibility, exclusion criteria, randomization and attrition of the 
participants within the study (Appendix G-3).  The data within the study were not 
specific concerning the original numbers of participants the sample was selected from nor 
were specific reasons for exclusions of the participants after the randomization was 
performed provided. 
 Another randomized control trail focusing on the effects of propofol on PAED 
scores within a pediatric population undergoing an adenotonsillectomy procedure was 
conducted by Lee et al. (2010) (Appendix F-1d, 2d).  This study included 88 patients 
ranging in age from 3- 8 years old.  All participants had an ASA score of 1.  Patients 
were randomly assigned to either receive propofol or to a control group receiving saline.  
Patients received 1mg/kg of intravenous thiopental pre-operatively.  Anesthesia was then 
induced with an additional 5mg/kg of thiopental and 0.5 mg/kg of atracurium.  An 
orotracheal intubation was performed and general anesthesia was maintained with 
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sevoflurane at 2-2.5% combined with a 50% nitrous oxide and oxygen mixture.  Either 1 
mg/kg of propofol or 0.1 ml/kg of saline was administered at the completion of the 
procedure after the inhalation agents were discontinued.  The PAED scores were obtained 
at five, 15 and 30 minute intervals after arrival to the PACU.  The average PAED scores 
for the propofol group were 12.6 at five minutes, 8.2 at 15 minutes and 5.0 at the thirty-
minute recording.  PAED scores for the saline group were increased at all three intervals 
with scores of 13.8, 8.0 and 4.5 respectively.  One patient from the trial had a parent 
present in the PACU.  Emergence times averaged 13.7 minutes for the propofol group 
and 12.2 minutes for the saline group.  Average time of discharge from the PACU was 
24.2 minutes within the propofol group and 25 minutes for the saline group.  Nausea and 
vomiting were reported in four of the propofol patients and six of those that received 
saline. No other adverse effects were reported. 
 Although this study showed a decrease in PAED scores within the propofol group 
there were significant limitations. The sample size was small and with P values between 
0.655 and 0.815 (Appendix F-3d), the results lacked significance.  The painful nature of 
the procedure made it difficult to determine whether the behaviors exhibited by the 
patient were related to post-operative pain or EA. 
 The study conducted by Lee et al. (Appendix G-4) reported participant selection, 
randomization and attrition using the CONSORT flow diagram.  Although the number of 
patients within the initial pool of participants was not specified, a total of 13 patients 
were lost after randomization.  Five patients from the propofol group did not receive the 
intervention related to severe agitation at induction, laryngospasm or an inadequate 
caudal block.  Eight patients from the control groups were eliminated for the same 
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reasons.  The data obtained from a patient within the propofol group was omitted related 
to ST depressions during the procedure.  A patient from the control group was also not 
included within the final analysis related to excessive surgical bleeding. 
Opthalmic procedures 
 The randomized control trial performed by Aouad et al. (2007) (Appendix F-1e, 
2e) involved 77 pediatric patients ranging in age from two to six years old.   The patients 
underwent either bilateral strabismus surgery (n = 23) or unilateral strabismus surgery (n 
= 18).  All the participants had an ASA of 2 or lower.  The mean duration of the 
procedures was 39 minutes.  Patients received oral midazolam (0.5mg/kg) 30 minutes 
prior to arrival to the operating room.  Mask inhalation induction was performed with 
sevoflurane and nitrous oxide and an LMA was implemented to maintain the airway.  
General anesthesia was maintained with 2-3% sevoflurane along with a 60% nitrous 
oxide and 40% oxygen mixture.  Antiemetic medications including paracetamol and 
dexamethasone were given peri-operatively.  At the completion of the procedure and 
once the inhaled anesthetics were discontinued, the propofol group received 1 mg/kg of 
propofol and the control group received an equivalent volume of saline. The PAED 
scores were obtained upon removal of the LMA and in unspecified time intervals until 
the patient was deemed calm.  The overall mean PAED score for the propofol group was 
8.6 + 3.9 compared to that of the saline group 11.5 + 4.5.  There were differences among 
the patients that underwent unilateral versus bilateral procedures.  The patients that 
received propofol had a mean PAED score of 8.3 + 2.7 while undergoing a unilateral 
procedure, whereas the patients that underwent bilateral procedures had a mean PAED 
score of 8.9 + 4.7.  The saline group also experienced an increase of PAED scores among 
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those that underwent a bilateral procedure.  Recipients of the saline intervention during a 
unilateral procedure had a mean PAED score of 10 + 4.  Those that underwent a bilateral 
procedure had an increased mean PAED score of 13.2 + 4.5.  Emergence times among 
the propofol group were slightly increased at 23.4 + 5.7 minutes compared to 19.7 + 5 
minutes experienced by the patients administered saline. All patients within this study 
had parental presence during the post recovery stage.  Discharge times from the PACU 
were not adversely affected by the administration of propofol compared to that of those 
that received saline.  The propofol group was discharged in an average of 34.1 + 8.4 
minutes whereas the saline group averaged 34.9 + 8.6 minutes.  Parents were present with 
all participants during the recovery stage and no adverse events were reported.  
 This study involved a procedure that has a high incidence of EA, making it a very 
relevant study to include in this systematic review (Appendix F-3e).  A decrease in 
PAED scores was demonstrated within the propofol group with a P value = .004.  
Although a significant correlation was reported, PAED scoring was more difficult within 
this patient population.  Forty-four patients within the propofol group had a unilateral 
procedure done, where as the remaining 56 patients had a bilateral procedure performed.  
There were 58 patients that received unilateral treatment and 42 patients that underwent 
bilateral procedures within the saline group.  One of the items within the PAED scoring 
system is for the child to make eye contact with the assessor. Due to the nature of this 
procedure and the location of bandages and protective eye wear, the PAED scores within 
this study may have been affected. 
 A CONSORT flow diagram was created to collect data regarding the selection 
and analysis of the participants (Appendix G-5).  The study did not include information 
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about the initial pool of participants nor detailed information about the one patient from 
the control group that was excluded from the final analysis.   
 Chen et al. (2010) (Appendix F-1f, 2f) conducted a randomized control trial 
involving 120 pediatric patients undergoing cataract surgery.  Laterality of the procedure 
was not specified.  The participants were aged from one to seven years old and all had 
ASA scores of 2 or less.   Average surgical time was 32 minutes. No medications were 
administered preoperatively and anesthesia was induced with sevoflurane and oxygen 
through mask inhalation.  Remifentanil (0.15 mcg/kg/min) was administered 
intravenously, along with a one-time dose of atropine (0.01 mg/kg).  An LMA was placed 
and general anesthesia was maintained with 1.5-2% sevoflurane and oxygen.  The 
remifentanil infusion was titrated to maintain ventilation (.05 – 0.25 mcg/kg/min). 
Patients were randomly assigned to one of three groups (n=40). Once the procedure was 
finished, children in the propofol group were administered 1mg/kg of propofol combined 
with 0.5 mcg/kg of fentanyl.   The ketamine group received 0.5 mcg/kg of ketamine 
combined with 0.5 mcg/kg of fentanyl, and the midazolam group received 0.05 mg/kg 
midazolam combined with 0.5 mcg/kg of fentanyl.  The PAED scores were recorded 
upon arrival at PACU and at five, 10, 15 and 30-minute intervals.  The number of 
patients with PAED scores higher than 10 and 15 were also recorded.  The mean PAED 
score of the propofol group was 6, with a score range of 3 to 15.  A total of eight patients 
had PAED scores equal or higher than 10, and an additional three patients scored a 15 or 
higher.  The ketamine group had a mean PAED score of 9 with a scores ranging from 3-
10.  Eighteen patients had a PAED score equal or greater than 10, and ten patients scored 
higher than 15.  Patients in the midazolam group had a mean PAED score of 5 with a 
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range of 2-15.  Six patients had PAED scores greater than or equal to 10, and only one 
patient had a score greater than 15.  Average emergence time for those patients in the 
propofol group was 17.0 + 2.1 minutes.  The midazolam and ketamine groups had 
average emergence times of 21.2 + 3.5 minutes and 19.4 + 5.2 minutes respectively.  
Average time to discharge for the propofol group was 27.3 + 4.9 minutes, where as the 
midazolam group experienced an average of 29.3 + 6.2 minutes and the ketamine group 
averaged 30.4 + 3.3 minutes.  Parental presence during recovery was not specified.  The 
ketamine group had two patients with hallucinations and nightmares. No other adverse 
reactions were reported. 
 The study conducted by Chen et al. (Appendix F-3f) had also demonstrated a 
significant decrease in PAED scores within the propofol group with a P value of <0.05.  
Limitations of this study included the lack of a placebo group as well as fentanyl being 
administered as part the interventions.  As with the previous study involving ocular 
procedures, visual acuity is affected and may make PAED scoring difficult in the post 
operative period. 
 A CONSORT flow diagram was created for this study to collect the data reported 
concerning the sample selection, allocation and attrition rates (Appendix G-6).  The study 
did not provide information regarding the initial patient pool from which their 
participants were selected.  There were no participants lost to follow up or analysis after 
the initial selection and randomization into treatment groups. 
Inguinal hernia procedures 
 Kim et al. (2012) (Appendix F-1g, 2g) compared the use of fentanyl and propofol 
for the prevention of EA in pediatric patients undergoing inguinal hernia repair.  All 
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patients were an ASA 2 or below.  A total of 205 patients ranging in age from one to six 
years old were randomly assigned to three groups.  A control group was administered an 
unspecified amount of saline at the completion of surgery.  Patients within the 
interventional groups received wither 1 mg/kg of propofol or 1 mcg/kg of fentanyl.  All 
patients received a caudal block with 0.5% bupivacaine (1.2 ml/kg) after a mask 
inhalation induction with 8% sevoflurane and placement of an LMA.  Anesthesia was 
maintained with sevoflurane 2-2.5% with a 50% oxygen flow.  No pre-medications were 
administered.  PAED scores were obtained upon the arrival to PACU and at five minute 
intervals for the first 30 minutes.  The average score was then reported for each group. 
The propofol group had a mean PAED score of 4.3, compared to 9.0 and 4.9 of the saline 
and fentanyl group respectively.  The average emergence time of the propofol group was 
27.7 minutes compared to the 17.6 minutes of the saline group and 17.6 minutes of the 
fentanyl group.  Discharge from PACU took an average of 37.1 minutes for the propofol 
group and 33.4 minutes for the saline group.  The fentanyl group was the most delayed 
with an average time of 40.4 minutes.  There were no parents present in the PACU during 
this trial.  Airway obstruction was noted in two patients within the propofol group and 
four that received fentanyl.  Laryngospasm was reported in one patient in both the 
propofol and fentanyl groups.  Nausea and vomiting was present in four of the propofol 
patients, two of the saline participants and 17 of those patients that received fentanyl.  No 
other adverse reactions were reported. 
 This study had the advantage of a large sample size and reported a significant 
correlation between the administration of propofol and decreased PAED scores with a P 
value of <0.001 (Appendix F-3g).  The use of a caudal block deemed this a relatively 
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painless procedure, eliminating the chance of post operative pain being assessed as EA.  
Limitations of this study included the elimination of patients that showed anxiety pre-
operatively which is considered a contributing factor to EA.  Inguinal hernia repair has a 
low incidence of EA making the results of the study less generalizable to other pediatric 
surgical procedures. 
 The CONSORT flow diagram was used in the study to report data related to 
sample selection, allocation and attrition (Appendix G-7).  Of the original 265 patients 
assessed for the study, 43 were excluded related either not meeting inclusion criteria or 
declining to participate.  Of the patients that were selected and randomized into 
interventional groups, 17 were not included in the study due to either extreme agitation 
during induction, laryngospasm or inadequate caudal blocks. 
Cross Study Analysis 
 The randomized control trials used for this systematic review were analyzed 
across studies utilizing the data collection sheet previously depicted in Table 2.  This tool 
was used to record and analyze the PAED scores, emergence times, discharge times and 
adverse effects amongst the propofol and control groups for each review (Appendix H). 
 All the randomized control trials included within this systematic review reported a 
decrease in PAED scores for children who received propofol prior to emergence after 
receiving a sevoflurane based general anesthetic (Appendix H-1, 2, 3, 4, 5, 6, 7).  The 
most profound decreases were found within the studies involving non-painful procedures 
such as outpatient MRI procedures.  The study conducted by Abu-Shahwan (Appendix 
H-1) reported a peak PAED score of seven (P < 0.05) within the propofol group 
compared to that of 13 (P < 0.05) of the control group.  Costi (Appendix H-2) reported a 
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peak PAED score of six (P < 0.001) within the propofol group compared to a peak score 
of 10 within the control group. 
 The seven studies also did not report a significant change in either the average 
emergence times nor the time of discharge from the post recovery area between the 
propofol and control groups (Appendix H).  Five studies reported increased emergence 
times for the propofol groups ranging from 1.5 to 10 minutes (Appendix H-1, 2, 4, 5, 7).  
One study reported a decrease in emergence time of 1.6 minutes (Appendix H-3), 
whereas the remaining study did not contain a control group for which a comparison 
could be made (Appendix H-6).  Discharge times were increased from between 0.6 to 3.7 
minutes in two of the studies included within this review (Appendix H-3, 7).  Four trials 
reported an overall decrease in discharge times ranging from 0.8 to 4 minutes (Appendix 
H-1, 2, 4, 5).  One trial did not contain a control group for which a comparison could be 
made (Appendix H-6).  
 There were few adverse effects reported within the propofol groups of the studies 
included with this systematic review.  Three studies reported no adverse effects for both 
the control and interventional groups (Appendix H-1, 5, 6). Nausea and vomiting was 
reported in three studies (Appendix H-3, 4, 7) and was the most common adverse event 
within the propofol groups.  Laryngospasm was the second most common adverse effect 
and was reported within two of the studies for the children that received propofol 
(Appendix H-2, 7).  
 Next, summary and conclusions section will be presented. 
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Summary and Conclusions 
 Emergence agitation among pediatric patients undergoing general anesthesia is a 
disruptive phenomenon.  Children that experience EA are at a greater risk of self-injury, 
interruption of medical treatment, increased stress upon caregivers and longer lengths of 
stays (Vlajkovic & Sindjelic, 2007).  Sevoflurane has been associated with an increased 
rate of EA in as high as 80% of children undergoing procedures under general anesthesia 
(Kim et al., 2011).  A literature review was conducted and found that although many 
systematic reviews and meta-analyses existed, there was a lack of a single consistent 
method of detecting and quantifying EA. The PAED scale is a five-item tool designed to 
quantify emergence agitation in the pediatric patient (Sikich & Lerman, 2004). This scale 
was developed to provide a consistent and reliable tool in which EA can be measured.  It 
is for this reason the author chose studies that incorporated this tool for the purpose of 
evaluating EA in their patient populations.  The purpose of this paper was to conduct a 
systematic review to determine if the administration of a sub-hypnotic dose of propofol 
would decrease the incidence and severity of the emergence agitation based upon PAED 
scores in children undergoing general anesthesia with sevoflurane. 
 A literature review was conducted utilizing inclusion and exclusion criteria 
created by the author.  The PRISMA flowchart (Figure 2) was used to assist in the 
organization and collection of data regarding the literature search.  A total of eight 
articles were selected, seven of which were randomized control trials.  The randomized 
control trials were subject to further critique using the CONSORT checklist (Appendix 
B) in order to assure the strength and significance of the studies included within this 
systematic review.  Data were collected from the articles and recorded within tables 
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created by the author (Appendix C).  Information that was obtained from each study 
included title, author, publication date, number of patients in trial, ages of participants, 
gender, ASA score, procedure performed, duration of procedure, allocation of 
participants to control and propofol groups, dose of propofol, intervention doses, timing 
of administration, other medications given, PAED scores and times, parental presence, 
emergence times, discharge times, airway interventions and any adverse events reported 
(Appendix F-1,2).  Strengths and weaknesses from each study were recorded within 
another table created by the author of this review using the criteria listed within the 
CONSORT checklist (Appendix F-3).  The CONSORT flow diagram, which focuses on 
the sample size, randomization and attrition rates of participants, was completed for each 
randomized control trial (Appendix G – 1, 2, 3, 4, 5, 6, 7).  Analysis across the studies 
was performed utilizing the chart located in Appendix H.  This chart recorded the PAED 
scores, emergence times, discharge times and adverse effects of both the propofol and 
control groups for all seven randomized control trials. 
 All seven of the randomized control trials used for this review reported a decrease 
in PAED scores in patients that received at least 1 mg/kg of intravenous propofol prior to 
emergence (Appendix H-1, 2, 3, 4, 5, 6, 7).  The most profound decreases in PAED 
scores were found within the studies that did not involve painful procedures such as 
undergoing an MRI as an outpatient (Appendix H-1, 2). The patients in the Costi et al. 
study (Appendix H-2) received a higher dose of propofol than the other six studies; 
3mg/kg versus 1mg/kg.  This increased dose may have affected the PAED scores.  Abu-
Shahwan (Appendix F-2a) also looked at the effects of propofol on PAED scores among 
pediatric patients undergoing MRI and utilized the sub-hypnotic dose of propofol (1 
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mg/kg).  Pain can affect the ability to distinguish EA from delirious behavior associated 
with noxious stimuli, which can have a significant affect on the ability to accurately 
assess PAED scores.  Examination of the PAED scores of patients undergoing painless 
procedures helped to validate the effect of propofol on EA. 
 Procedures that are associated with more intraoperative and postoperative pain 
also showed a decrease in PAED scores when a sub-hypnotic dose of propofol was 
administered prior to emergence.  Pediatric patients undergoing adenotonsillectomy 
procedures were studied by Ali (Appendix H-3) and Lee (Appendix H-4).  The study 
conducted by Lee reported decreased initial average PAED scores within the propofol 
group (12.6) as compared to that of the saline group (13.8).  Decreased PAED scores 
were also recorded in the Ali study with the propofol group having an initial average 
PAED score of 11.6 compared to that of the saline group, which averaged a score of 13.7.  
A third interventional group received dexmedetomidine and had an even lower reported 
average PAED score of 9.8.  Adenotonsillectomies are a more painful procedure than that 
of an MRI and a patient’s response to pain may be misread as EA.  It may be for these 
reasons that the overall PAED scores are higher than those in the studies involving the 
MRI and the differences between the saline group and propofol group less significant.  
The use of precedex provided the lowest severity of EA and could be attributed to its 
analgesic effects for which propofol lacks.  
 All seven of the studies did not report a significant increase in either the average 
emergence times nor the time of discharge from the post recovery area between the 
propofol and control groups (Appendix H-1, 2, 3, 4, 5, 6, 7).  The propofol groups had 
emergence times between 2 and 6 minutes longer than the control groups in six of the 
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studies (Appendix H-1, 2, 4, 5, 7).  The study conducted by Kim et al (Appendix H-7) 
had an emergence time among the propofol group that was 10 minutes longer than the 
control group.  This may have been attributed to the analgesic effects of the caudal block 
administered prior to the procedure.  Discharge from the post recovery area was also not 
greatly affected by the administration of propofol prior to emergence.  In two of the 
studies the discharge time increased by 0.6 to 4 minutes (Appendix H-3, 7).  Four studies 
(Appendix H-1, 2, 4, 5) showed a decrease in discharge times within the propofol group 
when compared to those patients within the control group.  The one study that lacked a 
control group had a discharge of time of 27.3 + 4.9 minutes (Appendix H-6).  
 Adverse effects were reported in four of the seven randomized control trials 
(Appendix H-2, 3, 4, 7).  Laryngospasms, airway obstruction, and post-operative nausea 
and vomiting (PONV) were the most commonly reported events.  The patients with 
reported episodes of PONV within the propofol groups (Appendix H-3, 4, 7) were within 
studies that included procedures with an existing higher incidence of PONV such as 
strabismus surgery and adenotonsillectomy procedures (Appendix H-4, 5).  
 Although diversity amongst the procedures performed provided stronger evidence 
for this systematic review, the differences amongst the timing and recording of PAED 
scores potentially weakened the conclusions that can be drawn from the data synthesis.  
The PAED scores were recorded at various time intervals, and in the case of the study 
conducted by Aouad (Appendix F-2e) time intervals were not accurately described.  
Studies differed on their reporting of PAED scores by the means of average scores, peak 
scores, ranges and number of patients that achieved scores higher than 10 or 15.  A 
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consistent scoring timeline and recording algorithm would have provided stronger 
evidence of the effect of propofol on the reduction of PAED scores. 
 There were limitations of this systematic review process.  Though the studies 
included in this review met the inclusion criteria, which were identified as reasonable, the 
inclusion of seven randomized control trials with relatively small sample sizes overall 
may lessen the generalizability to the pediatric surgical population at large.  This review 
may have benefitted from selecting trials of subjects undergoing identical surgical 
procedures.  Variables such as pain and body systems affected would not have been able 
to potentially affect the PAED scores.  Non-painful procedures, such as outpatient MRI 
studies and inguinal hernia repairs performed under a caudal block (Appendix F-2a, 2b, 
2g) were stronger studies related to eliminating the risk of interpreting the patients’ 
response to pain as EA.  In contrast, adenotonsillectomy procedures (Appendix F-2c, 2d), 
which are associated with more discomfort post-operatively, had higher PAED scores 
than that of the MRI studies (Appendix F-2a, 2b, 2c, 2d).  These higher PAED scores 
may not have been a direct reflection of EA, but rather of the misinterpretation of the 
child’s response to pain.  Studies that included patients undergoing ophthalmic 
procedures (Appendix F-2e, 2f) were at risk for obtaining weakened results related to the 
inability to assess accurate PAED scores.   One of the items on the PAED scoring system 
included making eye contact with the assessor (Figure 1).  Due to decreased visual acuity 
related to the procedure itself and subsequent bandages and protective eye wear required 
post operatively, the inability to assess this portion of the PAED scoring system may 
have affected the strength of the results. 
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 Despite these limitations, this systematic review provides sufficient evidence to 
implicate propofol as an effective means to reduce EA in the pediatric patient population.  
Recommendations and implications for advanced nursing practice will be discussed in 
the next section. 
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Recommendations and Implications for Advanced Nursing Practice 
 Certified Registered Nurse Anesthetists (CRNAs) are Advanced Practice 
Registered Nurses (APRNs) that rely on evidence-based research daily.  Systematic 
reviews provide the tools and evidence required in order to provide safe anesthesia.  
CRNAs are responsible for the peri-operative care of the pediatric patient.  CRNAs 
provide safe and uneventful emergency and recovery of the pediatric patient until the 
intraoperative report is conveyed to the Post Anesthesia Recovery Unit (PACU) nurse.  
Emergence agitation during emergence with the use of sevoflurane in the pediatric 
population makes waking increasingly unpredictable for the CRNA and operating room 
staff. 
 The administration of anesthesia is a combination of both a science and an art.  
Competence is achieved through education, clinical practice and developing a safe and 
effective technique of administering personalized and appropriate anesthesia.  Continuing 
education is crucial to both the education of the anesthesia provider and the safety of their 
patients.  Systematic reviews such as the one created by this author are intended to 
provide up to date information regarding the latest, safest and most effective methods of 
providing anesthesia across the lifespan.  This information can be used not only to 
improve the practice of existing practitioners, but also become incorporated in the 
curriculum of institutions training future CRNAs.  
 The use of propofol prior to emergence has been shown to decrease the PAED 
scores in children undergoing a variety of procedures in this systematic review.  Not only 
have the PAED scores been lowered, but also the overall emergence times and discharge 
from hospital times were minimally effected.  Many practitioners are hesitant in 
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administering propofol prior to emergence and extubation related to an increased risk of 
adverse effects such as airway obstruction and subsequent laryngospasm.  As the data 
within Appendix H shows, there were minimal events within the propofol group and no 
significant differences between those receiving either a control or alternate intervention.  
Propofol in sub-hypnotic doses is considered an anti-emetic within itself and can actually 
decrease the incidence of PONV (Miller, 2015).   
 Emergence agitation episodes can not only cause stress and increase the potential 
for injury for the patient, but it can also increase the stress and decrease the satisfaction of 
the caregiver/parent.  In the ever-changing field of health care, there has been a focus on 
patient satisfaction and most recently this has affected the reimbursement protocols for 
many Medicare and Medicaid patients.  If patients are dissatisfied with their care, 
including pain control and overall experience, the hospital may not be paid the full 
reimbursement allocated for the procedure.  Although pediatric patients often do not 
receive care from either the Medicare or Medicaid agencies, caution must be exercised if 
the trend continues in the future, other insurance plans and healthcare programs may 
follow suit and a wider population of patients may be affected.  Creation of policies that 
direct the CRNA to provide prophylactic measures to decrease the incidence and severity 
of EA may become commonplace as this emphasis on patient satisfaction continues. 
 This systematic review may also be the backboard to many future research 
endeavors.  Propofol was shown to decrease the incidence and severity of EA in the 
pediatric population, but as the study conducted by Ali (Appendix F-2c) reported, 
dexmedetomidine had an even greater effect on lowering PAED scores.  Future studies 
may be performed comparing dexmedetomidine and propofol and their effects on EA.   
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There are many other surgical and procedural factors that may be examined in relation to 
their effects on EA as a result of this systematic review.   Numerous variables could be 
further researched including surgical duration, patient gender and parental presence to see 
if they have an overall effect on PAED scores. These studies would be essential in 
developing even safer and more effective anesthetic protocols in the pediatric surgical 
population. 
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Appendix C 
Data Collection Sheet #2 
Author, 
Year 
Propofol 
Dose 
Intervention 
Doses 
Time of 
Intervention 
Anesthestics, 
Analgesia & 
other meds 
PAED 
Propofol 
Group 
PAED 
Interventional/ 
Control Group 
PAED 
scoring 
& 
timing 
Parental 
presence 
Emergence 
time 
Discharge 
Time 
Airway Adverse 
Effects 
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Appendix D 
Randomized Control Trial Appraisal Chart 
 
Author, Year Study Type Consent/Funding Inclusion 
Criteria 
Exclusion  
Criteria 
Randomization Attrition Blinding Strengths Limitations 
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Appendix E 
 
(Moher et al.From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For	more	information,	visit	www.prisma-statement.org. 
 
PRISMA FLOW DIAGRAM 
 
Records	identified	through	
PUBMED	search	
(n	=	38	)	
Sc
re
e
n
in
g	
In
cl
u
d
e
d
	
El
ig
ib
il
it
y	
Id
e
n
ti
fi
ca
ti
o
n
	
Records	identified	through	
MEDLINE	search	
(n	=	30	)	
Records	after	duplicates	removed	
(n	=	32		)	
Records	screened	
(n	=	32		)	
Records	excluded	
(n	=	10		)	
Full-text	articles	assessed	
for	eligibility	
(n	=	22	)	
Full-text	articles	excluded,	
with	reasons	
(n	=	14	)	
Studies	included	in	
qualitative	synthesis	
(n	=	8		)	
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Appendix F-1 
 
Data Collection Sheet #1 
 
 Author, Year # Patients 
in Trial 
Ages (yr) M/F ASA Procedures  Duration 
(min) 
Propofol 
Group 
Interventional 
Group 
a Abu-Shahwan, 
2008 
83 2-7 42/41 >2 Outpatient MRI 73 n = 42 Saline = 41 
b Costi, 2015 218 1-12 119/99 < 2 Outpatient MRI 64 n = 109 No intervention = 109 
c Ali, 2013 120 2-6 69/51 < 2 Adenotonsillectomy 58 n = 40 Saline =40 
Precedex = 40 
d Lee, 2010 88 3-8 51/37 < 2 Adenotonsillectomy 43 n = 44 Saline = 44 
e Auoad, 2007 77 2-6 40/37 < 2 Strabismus 39 n = 41 
unilateral = 18 
bilateral = 23 
Saline =36 
unilateral = 20 
bilateral = 16 
f Chen, 2010 120 1-7 49/71 < 2 Cataract 32 n = 40  
(w/ fentanyl) 
Ket/Fent = 40 
Midaz/Fent = 40 
g Kim, 2012 205 1-6 138/67 < 2 Inguinal hernia 62 n = 69 Fentanyl = 66 
Saline = 70 
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Appendix F-2 
Data Collection Sheet #2 
 Author, 
Year 
Propofo
l Dose 
Intervention
Doses 
Time of 
Intervention 
Anesthetics, 
Analgesia &  
other meds 
PAED 
propofol 
PAED 
intervent 
PAED 
scoring & 
timing 
Parental 
Presence 
Emerge 
Time  
(min) 
D/C 
Time 
Airway  Adverse 
Effects 
a Abu-
Shahwan, 
2008 
1 mg/kg Saline-no 
dose 
specified 
End of 
procedure 
after d/c of 
sevo and 
N2O, before 
LMA 
removal (no 
exact time 
specified) 
60% N20 
2% Sevo 
7 (P<0.05) Saline = 13 
(P<0.05 
awakening, 
q 5 min for 
1st 30 min. 
Peak scores 
recorded 
some 
parents 
were 
present, 
no exact 
% 
Propofo
l = 9 + 
3.4 
Saline =  
7 + 2.7 
 
P=ns 
Prop = 
31.21 + 
6.1 
Saline = 
33.4 + 
5.8 
 
P=ns 
LMA none 
b  Costi 3 mg/kg no 
intervention-
al group 
completion of 
MRI and d/c 
of sevo 
N2O – conc. 
not specified 
Sevo- conc. 
not specified 
peak = 6 
range = 2-
10 
 
P<0.001 
peak =10 
range =6-
13 
 
P<0.001 
arrival to 
PACU and 
5 min 
intervals 
for 1st 30 
min. Peak 
and range 
recorded 
not 
specified 
Prop = 
17 + 10 
Control 
9 + 10 
 
P<0.001 
Prop= 
95 + 38 
Control 
99 + 48 
 
P<0.001 
LMA Laryngo-
spasm 
occurred in 
3 from 
control and 
1 in 
propofol 
groups 
c Ali, 2013 1 mg/kg Saline 10ml 
Precedex 0.3 
mcg/kg 
5 min before 
end of 
surgery 
60% N2O  
2-3% Sevo 
Midazolam 
Paracetamol 
Decadron 
Rocuronium 
Neostigmine 
Atropine 
T0=11.6 
T5=6.6 
T15=5.7 
T30=4.1 
>15=3 
 
P<0.05 
Saline 
T0=13.7 
T5=8.4 
T15=5.7 
T30=4.2 
>15=7 
Precedex 
T0=9.8 
T5=5.2 
T15=4.2 
arrival to 
PACU(T0),
5,15,30 
min 
intervals. 
total # of 
pts with 
PAED >15 
recorded 
for each 
100% of 
patients 
with 
parents 
present 
Prop= 
12.3 
Saline= 
10.7 
Precede
x 
10.9 
 
P<0.05 
Prop= 
38.5 
Saline= 
37.9 
Precede
x 
40.1 
 
P<0.05 
ETT vomit in 
propofol 
group (5), 
saline (3) 
precedex 
(4) 
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T30=3.5 
>15=2 
 
P<0.05 
group 
d Lee, 2010 1 mg/kg Saline 
0.1mg/kg 
completion of 
procedure 
after d/c of 
inhalation 
agents 
N2O 50% 
Sevo 2-2.5% 
Thiopental 
Atracurium 
Ketorolac 
T5= 12.6 
T15= 8.2 
T30= 5.0 
 
P = 0.6-
0.8 
T5= 13.8 
T15= 8.0 
T30= 4.5 
 
P= 0.6-0.8 
5, 15 and 
30 min 
after arrival 
to PACU 
1 patient 
had 
parental 
presence 
prop= 
13.7 
saline= 
12.2 
prop= 
24.2 
saline= 
25 
ETT N/V 
prop (4) 
saline (6) 
e Auoad, 
2007 
1 mg/kg Saline – 
equal to 
volume of 
propofol 
completion of 
surgical 
procedure 
after d/c of 
inhalation 
agents 
60% N2O 
2-3% Sevo 
Midazolam 
Lidocaine 
Paracetamol 
Decadron 
Overall 
mean = 
8.6 + 3.9 
Unilat = 
8.3 + 2.7 
Bilat = 
8.9 + 4.7 
 
P=0.004 
 
Overall 
mean= 
11.5 + 4.5 
Unilat = 
10 + 4 
Bilat = 
13.2 + 4.5 
 
P=0.004 
@LMA 
removal 
cont. 
PAED 
recording, 
highest 
score used 
 
 
100% 
patient 
with 
parents 
present 
Prop = 
23.4 + 
5.7 
Saline = 
19.7 + 
5 
 
P=0.004 
Prop= 
34.1 + 
8.4 
Saline = 
34.9 + 
8.6 
 
P=0.68 
LMA none 
f Chen, 
2010 
1 mg/kg 
w/ 
fentanyl 
0.5 
mcg/kg 
midazolam – 
0.05mg/kg 
w/fentanyl 
0.5 mcg/kg 
 
Ketamine 
0.25 mg/kg 
w/fentanyl 
0.5 mcg/kg 
completion of 
procedure 
prior to d/c of 
inhalation 
agents and 
after d/c of 
remi 
fentanyl 
remifentanil 
atropine 
 
TIVA  
mean 6 
range  3-
10 
PAED>10 
= 8 
> 10 =8 
> 15 =3 
 
P<0.05 
Midaz 
mean 5 
range 2-15 
>10 = 6 
>15 =1 
Ketam 
mean 9 
range 3-20 
> 10 =18 
> 15 =10 
 
P<0.05 
 
 
 
 
 
arrival @ 
PACU, 5, 
10,15 & 30 
min. Mean 
PAED 
scores 
recorded. 
Also # of 
pts with 
scores > 10 
and 15 
not 
specified 
Prop = 
17.0 + 
2.1 
Midaz = 
21.2 + 
3.5 
Ketami
ne 
19.4 + 
5.2 
Prop = 
27.3 + 
4.9 
Midaz = 
29.3 + 
6.2 
Ketami
ne 
30.4 + 
3.3 
LMA ketamine 
group = 2 
patient with 
hallucin-
ations and 
night 
terrors 
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g Kim, 2012 1 mg/kg saline – 
unspecified 
amount 
fentanyl- 
1mcg/kg 
completion of 
surgery after 
d/c of sevo 
Caudal 
block with 
0.5% 
bupivacaine 
Sevo 2-2.5% 
 
mean = 
4.3 
 
P<0.001 
saline =9 
fent =4.9 
 
P<0.001 
 
arrival to 
PACU and 
5 min 
intervals 
for 1st 30 
min, mean 
scores 
evaluated 
no 
parents 
present 
Prop = 
27.7 
Saline = 
17.6 
Fentany
l 
17.6 
 
P<0.001 
Prop= 
37.1 
Saline= 
33.4 
Fentany
l 
40.4 
 
P<0.001 
LMA airway 
obstruct: 
prop (2) 
saline (0) 
fent (4) 
Laryngo-
spasm: 
prop (1) 
saline (0) 
fent (1) 
N/V: 
prop (4) 
saline (2) 
fent (17) 
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Appendix F-3 
Randomized Control Trial Appraisals   
 
 Author, 
Year 
Study Type Consent/ 
Funding 
Inclusion 
Criteria 
Exclusion 
Criteria 
Randomizatio
n 
Attrition Blinding Strengths Limitations 
a Abu-
Shahwan
, 2008 
Prospective 
Randomized 
Double 
Blinded 
ethics 
committee 
approval 
and parental 
consent 
 
no funding 
indicated 
ASA I-II, 
2-7 yo, 
elective 
MRI as 
outpatient 
with GA, 
normal 
cognitive 
function 
patients were 
excluded 
based on 
cognitive 
disorders, 
developmenta
l delay and 
the need for 
sedatives 
prior to 
induction 
randomized 
into two 
treatment 
groups using 
random 
number 
generator 
1 patient lost 
related to 
administration 
of propofol to 
placebo group 
intervention-
al and 
placebo 
administered 
by 
anesthesia 
assistant, 
EA 
evaluated by 
blinded 
recovery RN 
Generalizable - 
MRI is a non 
painful 
procedure and 
study was able 
to exclude pain 
as contributing 
factor to EA 
 
double blinded 
 
P<0.05, U-test, 
fisher’s exact 
test 
 
PAED 
scoring 
difficult in 
pediatric eye 
surgery r/t 
inability to 
make eye 
contact, 
increased 
difficulty 
with bilateral 
procedures 
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b Costi, 
2015 
Prospective 
Randomized 
Double 
Blinded 
Control 
Trial 
ethics 
committee 
approval & 
registered 
with 
Austrailian 
and NZ 
clinical trial 
registry, 
informed 
parental 
consent 
 
Funding- 
society for 
paediatric 
anaesthesia 
in New 
Zealand and 
Austrailia 
ASA I-II, 
age 1-12, 
undergoing 
MRI under 
GA 
performance 
of painful 
procedure, 
pupillary 
dilation, 
allergy to 
propofol or 
eggs, family 
history of MH 
randomly 
assigned to 
control or 
interventional 
group by 
computer 
generated 
numbers 
use of 
CONSORT 
flow diagram 
to report 
sample 
selection 
 
12 initially 
lost for 
refusal to 
participate 
 
no 
participants 
lost after 
randomization 
and allocation 
outcome 
assessor was 
blinded to 
intervention 
large patient 
sample 
 
provides 
insight on EA 
in patients 
undergoing 
non-painful 
procedures 
 
double blinded 
 
use of 
CONSORT 
flow diagram 
 
P<0.001 for 
PAED scores 
 
Data check 
with Shapiro 
wilks test 
some 
patients were 
administered 
propofol at 
induction 
 
higher 
propofol 
dose of 
3mg/kg 
administered 
 
P=0.573 for 
hospital 
discharge 
time – 
weakened 
signficance 
c Ali, 2013 Prospective 
Randomized 
Double 
Blinded 
IRB 
approval 
and written 
consent 
from parents 
 
no funding 
indicated 
ASA I-II, 
2-6 yo, 
elective 
adenotons- 
illectomy 
excluded 
mental 
disease, neuro 
disease and 
treatment with 
sedatives, full 
stomach or 
need for RSI 
randomized 
into 3 groups 
using 
computerized 
generated 
randomization 
table 
all patients 
that were 
enrolled 
completed the 
study 
IV meds 
prepared 
and hidden 
behind 
drapes.  
Anesthesia 
provider 
administered 
meds, 2nd 
blinded 
provider 
assessed 
PAED 
 
T&A surgery 
commonly 
performed in 
pediatric 
population. 
Demonstrated 
decreased 
PAED scores 
among 
propofol and 
precedex 
groups 
 
double blinded 
 
CONSORT 
not used in 
study – 
unclear 
original 
participant 
selection and 
attrition 
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d Lee, 
2010 
Prospective  
Randomized 
Double 
Blinded 
Control 
Trial 
IRB 
approval 
and written 
parental 
consent 
 
no funding 
indicated 
ASA I, 3-8 
yo, elective 
adenotonsi
-llectomy 
mental 
disease,neuro 
disease, 
sedative 
medication 
usage 
randomly 
assigned to 
one of two 
groups by 
computer 
generated 
numbers 
1 patient from 
propofol 
group 
dropped r/t 
ST depression 
on EKG, 1 
patient from 
saline group 
related to 
bleeding on 
extubation 
blinded 
anesthesia 
provider 
assessed 
PAED 
scores post-
operatively 
double blinded 
 
procedure with 
high incidence 
of EA 
difficulty 
determining 
if pain or 
delirium 
 
no 
significant 
decrease in 
EA within 
propofol 
group 
 
small sample 
e Auoad, 
2007 
Prospective 
Randomized 
Double 
Blinded 
Control 
Trial 
IRB 
approval 
and written 
parental 
consent 
 
no funding 
indicated 
ASA I-II, 
2-6 yo, 
elective 
strabismus 
surgery 
under GA 
Mental 
disease, neuro 
disease, 
sedatives, full 
stomach, RSI 
randomly 
assigned into 
propofol or 
control group 
using 
computer 
generated 
numbers 
3 patients 
were excluded 
from saline 
group r/t 
incomplete 
data 
collection 
anesthesia 
provider that 
collected 
data was 
blinded to 
which 
intervention 
was 
administered 
Generalizabilit
y - eye 
surgeries 
common with 
pediatric 
population, 
increased risk 
of PONV and 
EA 
 
P=.004 
 
double blinded 
PAED 
scoring 
difficult in 
pediatric eye 
surgery r/t 
inability to 
make eye 
contact, 
increased 
difficulty 
with bilateral 
procedures 
 
CONSORT 
flow diagram 
not used – no 
specific 
reporting of 
participant 
selection and 
attrition 
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f Chen, 
2010 
Prospective 
Randomized 
Double 
Blinded  
Control 
Trial 
ethics 
committee 
approval 
and parental 
consent 
 
no funding 
indicated 
ASA I-II, 
1-7 yo, 
elective 
cataract 
surgery 
behavioral 
problems & 
physical 
developmenta
l delay 
randomly 
assigned to 
one of three 
groups by 
means of 
computer 
generated 
numbers 
no patients 
were lost after 
initial 
enrollment 
blinded 
recovery 
nurse 
assessed 
PAED 
scores 
double blinded 
 
minimal pain 
involved in 
procedure – 
eliminate pain 
as cause of EA 
 
P<0.05 on 
PAED scores 
 
 
 
 
 
 
lack of 
placebo 
group 
 
fentanyl 
administered 
to all patients 
 
vision 
affecting 
PAED 
assessment 
 
no statistical 
analysis of 
emergence 
times or 
discharge 
time 
 
g Kim, 
2012 
Prospective 
Randomized 
Double 
Blinded 
Control 
Trial 
IRB 
approval 
and national 
registration 
parental 
consent 
 
Funding by 
departmenta
l monies 
ASA I-II, 
18-72 
months, 
elective 
inguinal 
hernia 
surgery in 
ambulatory 
care setting 
developmenta
l delay, 
psychologic 
or neurologic 
disorders, 
abnormal 
airway, 
reactive 
airway 
disease, 
history of 
general 
anesthesia 
randomly 
assigned to 
one of three 
groups by 
internet site 
program 
60 patients 
were lost 
during trial 
related to 
airway 
complications
, severe 
agitation at 
induction and 
failure to 
receive 
intervention 
syringes 
wrapped in 
foil by 
investigator 
not involved 
with 
anesthesia, 
assessors of 
PAED 
scores were 
blinded 
double blinded 
 
non-painful 
procedure 
inguinal 
hernia repair 
has low 
incidence of 
EA 
 
patients with 
preoperative 
anxiety 
excluded – 
contributor 
to EA 
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Appendix G-1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
 (n = 84) 
Excluded (n =0 ) 
 
  Not meeting inclusion criteria 
   (n =0) 
  Refused to participate 
   (n = 0) 
  Other reasons (n = 0) 
Randomized (n = 84) 
Allocated to Propofol 
Group 
(n = 42) 
 
Received allocated 
intervention (n = 42) 
 
Did not receive allocated 
intervention (n = 0) 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
Allocated to 
Saline/Control Group 
(n = 42) 
 
Received allocated 
intervention (n = 41) 
 
Did not receive allocated 
intervention (n = 1)  
 patient received 
propofol during procedure 
 
F
o
ll
o
w
 u
p
 
Lost to follow up  
(n  = 0) 
 
Discontinued intervention 
(n = 0) 
Lost to follow up  
(n = 0) 
 
Discontinued intervention 
(n = 0) 
A
n
a
ly
si
s Analyzed (n =  42) 
 
Excluded from analysis 
 (n = 0) 
Analyzed (n = 41) 
 
Excluded from analysis 
(n = 1) – lost previously r/t 
administration of propofol 
Abu-Shahwan, I. (2008). Effect of propofol on emergence behavior in children after  
 sevoflurane general anesthesia. Pediatric Anesthesia, 18, 55-59. 
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Appendix G-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
 (n = 242) 
Excluded (n = 12) 
 
  Refused to participate 
Randomized (n = 230) 
Allocated to Propofol 
Group 
(n = 115) 
 
Received allocated 
intervention (n = 114) 
 
Did not receive allocated 
intervention (n = 1) 
 subcutaneous injection 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
F
o
ll
o
w
 u
p
 Lost to follow up  
(n  = 0) 
 
Discontinued 
intervention (n = 0) 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
A
n
a
ly
si
s 
Analyzed (n =  109) 
 
Excluded from analysis 
 laryngospasm (n=2) 
 protocol violation (n=1) 
 assessor unblinded (n =1) 
 missing data (n=1) 
  
Costi, et al. (2015). Transition to propofol after sevoflurane anesthesia to prevent 
 emergence agitation: a randomized controlled trial. Pediatric Anesthesia, 5 (25), 
 517-523. 
Allocated to Control 
Group  
(n=  115) 
 
Received allocated 
intervention (n = 115) 
 
Did not receive allocated 
intervention (n = 0) 
 
Analyzed (n =  109) 
 
Excluded from analysis 
 laryngospasm (n=3) 
 protocol violation (n=1) 
 assessor unavail (n =1) 
 additional painful 
procedure (n=1) 
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Appendix G-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
 (n = original numbers not 
available) 
Excluded  
  
data not available 
Randomized (n = 120) 
Allocated to Propofol 
Group 
(n = 40) 
 
Received allocated 
intervention (n = 40) 
 
Did not receive allocated 
intervention (n = 0) 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
Allocated to 
Saline/Control Group 
(n = 40) 
 
Received allocated 
intervention (n = 40) 
 
Did not receive allocated 
intervention (n = 0)  
  
 
F
o
ll
o
w
 u
p
 Lost to follow up  
(n  = 0) 
 
Discontinued 
intervention (n = 0) 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
A
n
a
ly
si
s 
Analyzed (n =  40) 
 
Excluded from analysis 
 (n = 0) 
Analyzed (n = 40) 
 
Excluded from 
analysis 
(n = 0) 
lr/administration of 
propofol 
Ali, M.A., & Abdellatif, A.A. (2013). Prevention of sevoflurane related emergence 
 agitation in children undergoing adenotonsillectomy: A comparison of 
 dexmedetomidine and propofol. Saudi Journal of Anaesthesia, 7 (3), 296-300. 
Allocated to  
Dexmedetomidine 
Group 
(n = 40) 
 
Received allocated 
intervention (n = 40) 
 
Did not receive allocated 
intervention (n = 0) 
 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
Analyzed (n = 40) 
 
Excluded from analysis 
(n = 0) 
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Appendix G-4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
not available 
Excluded 
 
data not available 
 
Randomized (n = 90) 
Allocated to Propofol 
Group 
(n = 45) 
 
Received allocated 
intervention (n =69) 
 
Did not receive allocated 
intervention (n = 5) 
 severe agitation at 
induction, laryngospasm, 
inadequate caudal block 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
F
o
ll
o
w
 u
p
 Lost to follow up  
(n  = 0) 
 
Discontinued 
intervention (n = 1) 
ST depression 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 1) 
surgical bleeding 
A
n
a
ly
si
s 
Analyzed (n =  44) 
 
Excluded from analysis  
-see above 
  
 
Lee, C.J. et al. (2010). The effect on propofol on emergence agitation in children 
 receiving sevoflurane for adenotonsillectomy.  Korean Journal of 
 Anesthesiology, 2(52),  75-81. 
Allocated to Control 
Group  
(n=  45) 
 
Received allocated 
intervention (n = 66) 
 
Did not receive allocated 
intervention (n = 8) 
severe agitation, 
laryngospasm, inadequate 
caudal block 
 
Analyzed (n =  44) 
 
Excluded from analysis 
 - see above 
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Appendix G-5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
 not available 
Excluded  
 
 
not available 
 
Randomized (n = 80) 
Allocated to Propofol 
Group 
(n = 41) 
 
Received allocated 
intervention (n = 41) 
 
Did not receive allocated 
intervention (n = 0) 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
F
o
ll
o
w
 u
p
 Lost to follow up  
(n  = 0) 
 
Discontinued 
intervention (n = 0) 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
A
n
a
ly
si
s Analyzed (n =  41) 
 
Excluded from analysis 
 (n = 0) 
Analyzed (n = 36) 
 
Excluded from 
analysis 
(n = 3)  
excluded related to 
incomplete data 
collection 
Aouad, M.D. et al (2007). A single dose of propofol at the end of surgery for the 
 prevention of emergence agitation in children undergoing strabismus surgery 
 during sevoflurane anesthesia. Anesthesiology, 107, 733-738 
Allocated to 
Saline/Control Group 
 
Received allocated 
intervention (n = 39) 
 
Did not receive allocated 
intervention (n = 0) 
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Appendix G-6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
 (n = 120) 
Excluded (n =0 ) 
 
  Not meeting inclusion criteria 
   (n =0) 
  Refused to participate 
   (n = 0) 
  Other reasons (n = 0) 
Randomized (n = 120) 
Allocated to Propofol 
Group 
(n = 40) 
 
Received allocated 
intervention (n = 40) 
 
Did not receive allocated 
intervention (n = 0) 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
F
o
ll
o
w
 u
p
 Lost to follow up  
(n  = 0) 
 
Discontinued 
intervention (n = 0) 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
A
n
a
ly
si
s Analyzed (n =  40) 
 
Excluded from analysis 
 (n = 0) 
Analyzed (n = 40) 
 
Excluded from 
analysis 
(n = 0)  
 
Chen, J. et al. (2010).  Emergence agitation after cataract surgery in children: a 
 comparison of midazolam, propofol and ketamine. Pediatric Anesthesia, 20, 
 873-879. 
Allocated to Ketamine 
Group 
 
Received allocated 
intervention (n = 40) 
 
Did not receive allocated 
intervention (n = 0) 
 
Allocated to Midazolam 
Group 
 
Received allocated 
intervention (n = 40) 
 
Did not receive allocated 
intervention (n = 0) 
 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
Analyzed (n =  40) 
 
Excluded from analysis 
 (n = 0) 
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Appendix G-7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Assessed for eligibility 
 (n = 265) 
Excluded (n = 43) 
not meeting inclusion criteria 
(n=31) 
declined to participate (n=10) 
other reasons (n=2) 
 
Randomized (n = 222) 
Allocated to Propofol 
Group 
(n = 74) 
 
Received allocated 
intervention (n =69) 
 
Did not receive allocated 
intervention (n = 5) 
 severe agitation at 
induction, laryngospasm, 
inadequate caudal block 
 
A
ll
o
c
a
ti
o
n
 
E
n
r
o
ll
m
e
n
t 
F
o
ll
o
w
 u
p
 Lost to follow up  
(n  = 0) 
 
Discontinued 
intervention (n = 0) 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
A
n
a
ly
si
s 
Analyzed (n =  69) 
 
Excluded from analysis 
(n=0) 
  
 
Kim, Y.H. et al. (2012). Prophylactic use of midazolam or propofol at the end of surgery 
 may reduce the incidence of emergence agitation after sevoflurane anaesthesia. 
 Anaesthesia and Intensive Care, 39(5), 904-908. 
Allocated to Fentanyl 
Group  
(n=  74) 
 
Received allocated 
intervention (n = 66) 
 
Did not receive allocated 
intervention (n = 8) 
severe agitation, 
laryngospasm, inadequate 
caudal block 
 
Analyzed (n =  66) 
 
Excluded from analysis 
 (n=0) 
Allocated to Control 
Group  
(n=  74) 
 
Received allocated 
intervention (n = 70) 
 
Did not receive allocated 
intervention (n = 4) 
inadequate caudal block 
 
Lost to follow up  
(n = 0) 
 
Discontinued 
intervention (n = 0) 
Analyzed (n =  70) 
 
Excluded from analysis 
(n=0) 
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Appendix H 
Cross Study Analysis 
 Author, Year 
Type of Procedure 
Propofol Group –affect on  
PAED scores compared to 
control 
 
Propofol Group Affect on 
Emergence Times compared 
to control (min) 
Propofol Group Affect on 
Discharge Time compared 
to control (min) 
Adverse Events in 
Propofol group 
1 Abu-Shahwan, 2008 
 
Outpatient MRI 
Propofol = 7 
Control = 13 
 
(peak PAED) 
 
P<0.05 
 
decrease of 6 
Propofol = 9 + 3.4 
Control = 7 + 2.7 
 
P = ns 
 
increase of 2 min 
 
Propofol = 31.21 + 6.1 
Control = 33.4 + 5.8 
 
P= ns 
 
decrease of 2.2 min 
 
 
 
 
none 
2 Costi, 2015 
 
Outpatient MRI 
Propofol = 6 
Control = 10 
 
(Peak PAED scores) 
 
P<0.001 
 
decrease by 4 
Propofol = 17 + 10 
Control = 9 + 10 
 
P<0.001 
 
increase by 8 min 
Propofol = 95 + 38  
Control = 99 + 48 
 
P<0.001 
 
decrease by 4 min 
laryngospasm (n=1) 
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3 Ali, 2013 
 
Adenotonsillectomy 
Propofol = 11.6, 6.6, 5.2, 
4.1 
Control = 13.7, 8.4, 5.7, 
4.2 
 
(PAED scores at T0,5,15 
and 30) 
 
P<0.05 
 
overall decrease at all time 
intervals 
Propofol = 12.3 + 3.4 
Control =  10.7 + 2.5 
 
P<0.05 
 
decrease of 1.6 min 
Propofol = 38.5 + 5.3 
Control = 37.9 + 5.5 
 
P<0.05 
 
increase of 0.6 min 
vomiting (n=5) 
4 Lee, 2010 
 
Adenotonsillectomy 
Propofol = 12.6 , 8.2, 5.0 
Control = 13.8, 8.0, 4.5 
 
(score at 5,15 and 30 min) 
 
P value range from 0.655-
0.672 
 
overall decrease in PAED 
scores except at 15 min 
mark 
 
Propofol = 13.7 + 3.8 
Control = 12.2 + 4.1 
 
P = 0.188 
 
increase by 1.5 min 
 
 
Propofol = 24.2 + 5.0 
Control = 25.0 + 6.1 
  
P = 0.516 
 
decrease by 0.8 min 
nausea and 
vomiting (n=4) 
5 Auoad, 2007 
 
Strabismus 
Propofol = 8.6 + 3.9 
Control = 11.5 + 4.5 
(mean PAED) 
 
P=0.004 
 
decrease of 2.9 
Propofol = 23.4 + 5.7 
Control = 19.7 + 5 
 
P=0.004 
 
increased emergence time of 
3.7 min 
Propofol = 34.1 + 8.4  
Control = 35.9 + 8.6 
 
P=0.68 
 
decreased discharge time of 
1.8 min 
none 
 67 
 
6 Chen, 2010 
 
Cataract 
Propofol = 6 
 
(score in PACU) 
 
No Control group 
 
P< 0.05 
 
 
Propofol = 17.0 + 2.1 
 
No Control group 
 
No statistical analysis other 
than SD 
Propofol  = 27.3 + 4.9 
 
No Control group 
 
No statistical analysis other 
than SD 
none 
7 Kim, 2012 
 
Inguinal Hernia 
Propofol = 4.3 
Control = 9 
 
(mean PAED score) 
 
P<0.001 
 
decrease by 4.7 
 
Propofol= 27.7 
Control = 17.6 
 
P<0.001 
 
increase by 10.1 min 
Propofol = 37.1 
Control = 33.4  
 
P<0.001 
 
increase by 3.7 min 
airway obstruction 
(n=2) 
laryngospasm (n=1) 
nausea/vomiting 
(n=2) 
